Product Datasheet

 
Product Description
 
Product: Human coagulation Factor XII
Catalog Number: HFXII
Product Page: https://www.mol-innov.com/products/
Description: Human Factor XII is a single chain glycoprotein prepared from fresh human plasma by ion exchange chromatography. Factor XII is converted, principally from the action of kallikrein, into an active serine protease (Factor alpha-Xlla) that functions in the in vivo initiation of blood coagulation, fibrinolysis, and kinin formation. Purity of Factor XII is >95percent by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I & II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease).
Recommended Storage: SAMPLE
Minimum Shelf Life: 308.75
Source: 2.0 mg/ml
Molecular Weight: Proteins
Extinction Coefficient: 80,000
Antigen: -70 C
Target: Frozen liquid
Target Molecular Weight: FACTOR XII
Host: 517.75
Clonality: 5
Isotype: Human plasma
Clone: s
Applications: Dry ice
Cross-reactivity: 3 years from delivery
Concentration: 325
Volume: 545
Titer: 4 mM Sodium Acetate; 0.15 M NaCl; pH 5.3
Buffer: SAMPLE
Form: 0.5 mg
Preservative: 0.25 ml
 
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet.
 
For in vitro laboratory use only
 
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA
Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com